TRAF3 and systemic lupus erythematosus: Furthermore, genome-wide association studies (GWAS) and targeted analyses demonstrated that common genetic variants of TRAF3, which reduce TRAF3 expression, are associated with an increased risk of B cell malignancies, systemic lupus erythematosus, hypergammaglobulinemia, and recurrent bacterial infection in a wider population (14).